Breast Cancer, Cervical Cancer, Colorectal Cancer
Conditions
Keywords
general practitioner, screening, participation, organized screening
Brief summary
Our goal is to evaluate, in France, the effectiveness (in terms of participation) of the general practitioner involvement (signature) and a more personalized communication in invitation letters to organized screening of breast, colorectal and cervical cancers. The hypothesis on which this project is based is that communication is probably more effective if the receiver feels personally targeted by invitation letters (Dear Martin, I am writing ...) and if he knows the issuer (his general practitioner rather an unknown person).
Interventions
No modification and signed by the coordinating doctor as usual
Invitation with revised text and layout and signed by the coordinating doctor as usual
signature typed or typed + handwritten
Sponsors
Study design
Eligibility
Inclusion criteria
* Living in Indre-et-Loire (french territorial division 37) * Be affiliated to the following three health insurance companies: CPAM (Caisse Primaire d'Assurance Maladie), MSA (Mutualité Sociale Agricole), or RSI (Régime social des Indépendants) * Having declared (to health insurance company) an attending physician who has given its written consent to participate in the study * Present no exclusion criterion to cancer screening ( for each one) * Be old from 50 to 74 years (breast and colorectal cancer) or from 25 to 65 years (cervical cancer)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluate the effect on the participation (of the population) in cancer screening of an intervention involving the general practitioner (integration of signature) in the invitation letters | 9 or 12 months after the invitation letters | The participation / non participation will be measured for each cancer screening (breast, colorectal and cervical) : * 9 months after the invitation letters for breast and colorectal cancers * 12 months after the invitation letters for cervical cancer The participation rate is defined as the number of people having participated, divided by the total number of people in the group or subgroup considered. Analysis by comparing the participation rates between groups (Group 1, Group 2 and Group 3) and sub-groups will be done. |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the effectiveness on the participation (of the population) of the use of a simplified and more focused communication in the invitation letters : comparison of the participation rates in arm 1 (normal invitation) and arm 2 (revised invitation) | 9 or 12 months after the invitation letters |
| Evaluate the effectiveness on the participation (of the population) of the two types of general practitioner signature (typed versus typed + handwritten) by comparing the participation rates between two sub-groups in the arm 3. | 9 or 12 months after the invitation letters |
| Cost-effectiveness of different strategies for each cancer screening (breast, colorectal and cervical) as measured by cost effectiveness ratio (total costs in Euros divided by total screened people) | 9 or 12 months after the invitation letters |
Countries
France